Health, Vaccines, Lyme Disease, FDA, Medicine.
because it was so problematic, and that issue was not really addressed.” Clarifying the improvements inherent in new strategies will be crucial, she says. It remains unclear how Valneva will address past failures if, in fact, the company brings a vaccine to market. With the vaccine still in safety